New mRNA flu shots show promise in large adult trial

NCT ID NCT07121192

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested new mRNA-based seasonal flu vaccines in 776 healthy adults aged 18 and older. The goal was to see how safe the vaccines are and how well they boost the immune system. Researchers measured side effects and immune responses to find the best vaccine candidate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Infections viral infectious disease influenza prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • GSK Investigational Site

    Anniston, Alabama, 36207, United States

  • GSK Investigational Site

    Fair Oaks, California, 95628, United States

  • GSK Investigational Site

    San Diego, California, 92120, United States

  • GSK Investigational Site

    San Diego, California, 92123, United States

  • GSK Investigational Site

    Walnut Creek, California, 94598, United States

  • GSK Investigational Site

    Hialeah, Florida, 33012, United States

  • GSK Investigational Site

    Jupiter, Florida, 33458, United States

  • GSK Investigational Site

    Miami, Florida, 33186, United States

  • GSK Investigational Site

    Stockbridge, Georgia, 30281, United States

  • GSK Investigational Site

    Valparaiso, Indiana, 46383, United States

  • GSK Investigational Site

    Lenexa, Kansas, 66219, United States

  • GSK Investigational Site

    Springfield, Massachusetts, 01103, United States

  • GSK Investigational Site

    Carson City, Nevada, 89706, United States

  • GSK Investigational Site

    Rochester, New York, 14609, United States

  • GSK Investigational Site

    Greensboro, North Carolina, 27408, United States

  • GSK Investigational Site

    Cleveland, Ohio, 44122, United States

  • GSK Investigational Site

    North Charleston, South Carolina, 29405, United States

  • GSK Investigational Site

    Austin, Texas, 78705, United States

  • GSK Investigational Site

    DeSoto, Texas, 75115, United States

  • GSK Investigational Site

    Fort Worth, Texas, 76135, United States

  • GSK Investigational Site

    Newport News, Virginia, 23606, United States

  • GSK Investigational Site

    Seattle, Washington, 98104, United States